Nu Skin Enterprises, Inc.
NUS
$4.79
$0.091.92%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 320.11M | 320.61M | 370.32M | 364.21M | 386.14M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 320.11M | 320.61M | 370.32M | 364.21M | 386.14M |
| Cost of Revenue | 101.79M | 106.15M | 108.34M | 107.49M | 120.41M |
| Gross Profit | 218.33M | 214.46M | 261.98M | 256.72M | 265.73M |
| SG&A Expenses | 198.77M | 208.60M | 238.74M | 235.08M | 234.95M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 300.56M | 314.74M | 347.08M | 342.57M | 355.36M |
| Operating Income | 19.56M | 5.87M | 23.24M | 21.64M | 30.78M |
| Income Before Tax | -63.18M | 2.60M | 18.19M | 15.99M | 27.41M |
| Income Tax Expenses | 186.62M | 763.00K | 3.70M | -1.09M | 6.29M |
| Earnings from Continuing Operations | -249.80M | 1.84M | 14.49M | 17.08M | 21.12M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -249.80M | 1.84M | 14.49M | 17.08M | 21.12M |
| EBIT | 19.56M | 5.87M | 23.24M | 21.64M | 30.78M |
| EBITDA | 32.21M | 18.21M | 36.16M | 33.73M | 43.83M |
| EPS Basic | -5.14 | 0.04 | 0.30 | 0.35 | 0.43 |
| Normalized Basic EPS | 0.20 | 0.06 | -0.13 | 0.56 | 0.35 |
| EPS Diluted | -5.14 | 0.04 | 0.28 | 0.34 | 0.43 |
| Normalized Diluted EPS | 0.20 | 0.06 | -0.12 | 0.55 | 0.35 |
| Average Basic Shares Outstanding | 48.60M | 48.20M | 48.58M | 49.40M | 49.44M |
| Average Diluted Shares Outstanding | 48.60M | 49.42M | 49.91M | 50.31M | 49.50M |
| Dividend Per Share | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 |
| Payout Ratio | -1.17% | 156.48% | 20.05% | 17.34% | 14.03% |